225 related articles for article (PubMed ID: 15527743)
41. Development of delta-opioid receptor subtypes and the regulatory role of weaning: radioligand binding, autoradiography and in situ hybridization studies.
Kitchen I; Leslie FM; Kelly M; Barnes R; Crook TJ; Hill RG; Borsodi A; Toth G; Melchiorri P; Negri L
J Pharmacol Exp Ther; 1995 Dec; 275(3):1597-607. PubMed ID: 8531134
[TBL] [Abstract][Full Text] [Related]
42. Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine.
Townsend D; Portoghese PS; Brown DR
J Pharmacol Exp Ther; 2004 Jan; 308(1):385-93. PubMed ID: 14569065
[TBL] [Abstract][Full Text] [Related]
43. GABA and opioid binding distribution in the brain of the seizure-resistant Proechimys guyannensis: an autoradiography study.
Rocha L; Arida RM; Carvalho Rde A; Scorza FA; Neri-Bazan L; Cavalheiro EA
Synapse; 2006 Oct; 60(5):392-8. PubMed ID: 16847947
[TBL] [Abstract][Full Text] [Related]
44. Ethanol exposure differentially alters pro-enkephalin mRNA expression in regions of the mesocorticolimbic system.
Méndez M; Morales-Mulia M
Psychopharmacology (Berl); 2006 Nov; 189(1):117-24. PubMed ID: 17047937
[TBL] [Abstract][Full Text] [Related]
45. [Inhibition of the expression of delta opioid receptor mRNA by long-term exposure of NG-108-15 cell line to delta opioid agonists].
Wang Y; Wang XM; Han JS
Sheng Li Xue Bao; 1998 Apr; 50(2):217-21. PubMed ID: 11324539
[TBL] [Abstract][Full Text] [Related]
46. Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway.
Yamamura S; Ohoyama K; Nagase H; Okada M
Neuropharmacology; 2009 Sep; 57(3):322-31. PubMed ID: 19482038
[TBL] [Abstract][Full Text] [Related]
47. Anti-exudative effects of opioid receptor agonists in a rat model of carrageenan-induced acute inflammation of the paw.
Romero A; Planas E; Poveda R; Sánchez S; Pol O; Puig MM
Eur J Pharmacol; 2005 Mar; 511(2-3):207-17. PubMed ID: 15792790
[TBL] [Abstract][Full Text] [Related]
48. Effect of chronic social stress on delta-opioid receptor function in the rat.
Pohorecky LA; Skiandos A; Zhang X; Rice KC; Benjamin D
J Pharmacol Exp Ther; 1999 Jul; 290(1):196-206. PubMed ID: 10381776
[TBL] [Abstract][Full Text] [Related]
49. Alteration of kappa-opioid receptor system expression in distinct brain regions of a genetic model of enhanced ethanol withdrawal severity.
Beadles-Bohling AS; Wiren KM
Brain Res; 2005 Jun; 1046(1-2):77-89. PubMed ID: 15869750
[TBL] [Abstract][Full Text] [Related]
50. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain.
Liang Y; Boules M; Shaw AM; Williams K; Fredrickson P; Richelson E
Brain Res; 2008 Sep; 1231():6-15. PubMed ID: 18687313
[TBL] [Abstract][Full Text] [Related]
51. Functional reduction in mu-opioidergic system in the spinal cord under a neuropathic pain-like state following chronic ethanol consumption in the rat.
Narita M; Miyoshi K; Narita M; Suzuki T
Neuroscience; 2007 Feb; 144(3):777-82. PubMed ID: 17156932
[TBL] [Abstract][Full Text] [Related]
52. Modulation of dopamine release by striatal 5-HT2C receptors.
Alex KD; Yavanian GJ; McFarlane HG; Pluto CP; Pehek EA
Synapse; 2005 Mar; 55(4):242-51. PubMed ID: 15668911
[TBL] [Abstract][Full Text] [Related]
53. [3H]ethylketocyclazocine binding to brain opioid receptor subtypes in alcohol-preferring AA and alcohol-avoiding ANA rats.
Soini SL; Honkanen A; Hyytiä P; Korpi ER
Alcohol; 1999 May; 18(1):27-34. PubMed ID: 10386662
[TBL] [Abstract][Full Text] [Related]
54. Prenatal ethanol exposure alters met-enkephalin expression in brain regions related with reinforcement: possible mechanism for ethanol consumption in offspring.
Abate P; Hernández-Fonseca K; Reyes-Guzmán AC; Barbosa-Luna IG; Méndez M
Behav Brain Res; 2014 Nov; 274():194-204. PubMed ID: 25150040
[TBL] [Abstract][Full Text] [Related]
55. Autoradiographic analysis of 5-hydroxytryptamine 5-HT2A binding sites in the rat brain after chronic intragastric ethanol treatments.
Fedeli A; Ciccocioppo R; Economidou D; Angeletti S; Massi M
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):113-27. PubMed ID: 15080502
[TBL] [Abstract][Full Text] [Related]
56. Alterations in dopamine D3 receptors in the circling (ci3) rat mutant.
Schirmer M; Nobrega JN; Harrison SJ; Löscher W
Neuroscience; 2007 Feb; 144(4):1462-9. PubMed ID: 17187934
[TBL] [Abstract][Full Text] [Related]
57. Selective delta-opioid receptor antagonist N,N(CH3)2-Dmt-Tic-OH does not reduce ethanol intake in alcohol-preferring AA rats.
Ingman K; Salvadori S; Lazarus L; Korpi ER; Honkanen A
Addict Biol; 2003 Jun; 8(2):173-9. PubMed ID: 12850776
[TBL] [Abstract][Full Text] [Related]
58. Mu-opioid receptors are involved in the tolerance to nicotine antinociception.
Galeote L; Kieffer BL; Maldonado R; Berrendero F
J Neurochem; 2006 Apr; 97(2):416-23. PubMed ID: 16539669
[TBL] [Abstract][Full Text] [Related]
59. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K
Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239
[TBL] [Abstract][Full Text] [Related]
60. Impact of 6-hydroxydopamine lesions and cocaine exposure on mu-opioid receptor expression and regulation of cholinergic transmission in the limbic-prefrontal territory of the rat dorsal striatum.
Jabourian M; Pérez S; Ezan P; Glowinski J; Deniau JM; Kemel ML
Eur J Neurosci; 2007 Mar; 25(5):1546-56. PubMed ID: 17425581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]